Maurer J
Klinik für HNO-Krankheiten, Kopf-Hals-Chirurgie & Centrum für Hören und Kommunikation, Katholisches Klinikum Koblenz, Koblenz, Deutschland.
HNO. 2009 Mar;57(3):199-207. doi: 10.1007/s00106-008-1852-5.
As yet comparatively little experience has been gained with fully implantable hearing systems, as the two systems available at present have only recently received CE permission for Europe and the FDA permissions are still pending in the USA. Additionally the technology is expensive and usually not covered by insurance companies. However, it could be shown that by careful patient selection and very careful surgical techniques, good results can be achieved with this highly sensitive technology, often with better patient satisfaction and hearing quality than with conventional hearing aids. To spread the technology further, the systems must also show reliable results on a broad application. Further surgery to change the batteries should not be necessary more frequently than with cardiac pacemakers. Not all technical problems are finally solved. However, it is to be foreseen that fully implantable hearing systems will be a good long-term alternative to conventional hearing aids for some patients.
目前,对于完全植入式听力系统的经验相对较少,因为目前可用的两种系统最近才获得欧洲的CE许可,而在美国,FDA的许可仍在审批中。此外,该技术价格昂贵,通常不在保险公司的承保范围内。然而,可以证明,通过仔细的患者选择和非常精细的手术技术,使用这种高度敏感的技术可以取得良好的效果,患者满意度和听力质量通常比传统助听器更好。为了进一步推广该技术,这些系统还必须在广泛应用中显示出可靠的效果。更换电池的进一步手术频率不应比心脏起搏器更频繁。并非所有技术问题都最终得到解决。然而,可以预见,对于一些患者来说,完全植入式听力系统将是传统助听器的一个很好的长期替代品。